MarketPeel
Insider Trading Intelligence
JK

Joseph III Klein

IONS
DIRECTOR · IONIS PHARMACEUTICALS INC · CIK 0001206369
FILING MIX · LIFETIME40%/60%
BUYS
36
SELLS
53
TOTAL VALUE
$13.09M
COMPANIES
1
ACTIVE SINCE
Jul 2020
HOLDINGS NOW
11,014
AVG SELL PX
$64.01
TRADE KIND
SHOWING 89 / 89
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
24 backtested trades · 8 horizons · 28 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Joseph III Klein, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d24+70.83%-2.41%+1.09%-3.49%-3.36%
14d24+66.67%-3.93%+2.30%-6.23%-4.57%
30d24+62.50%-0.77%+2.84%-3.83%-3.68%
60d24+25.00%+4.46%+4.64%+0.06%-0.17%
90d24(2 pending)+31.82%+10.16%+5.34%+6.86%+15.73%
180d24(7 pending)+82.35%-4.03%+12.03%-15.89%-20.61%
1y24(9 pending)+66.67%-9.91%+17.33%-27.24%-34.16%
2y24(10 pending)+14.29%+42.53%+41.03%+1.50%+1.96%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IONS · 11,014 shares · as of Jul 1, 2026
08,33416,66825,00133,335202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 36 buys / 53 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IONS
IONIS PHARMACEUTICALS INC
SALE
11,5180Jul 1, 2026Jul 6, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
11,518$39.94$460.0K22,532Jul 1, 2026Jul 6, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
99$79.45$7.9K22,433Jul 1, 2026Jul 6, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
11,419$79.04$902.6K11,014Jul 1, 2026Jul 6, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,30116,277Jul 1, 2026Jul 6, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,3695,369Jul 1, 2026Jul 6, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
10,1110May 1, 2026May 4, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
1,431$74.45$106.5K11,014May 1, 2026May 4, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
10,111$47.11$476.3K21,125May 1, 2026May 4, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
8,680$73.35$636.7K12,445May 1, 2026May 4, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
20,105$75.50$1.52M13,230Apr 1, 2026Apr 2, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
2,216$75.95$168.3K11,014Apr 1, 2026Apr 2, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
10,3210Apr 1, 2026Apr 2, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
12,0000Apr 1, 2026Apr 2, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
12,000$38.06$456.7K23,014Apr 1, 2026Apr 2, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
10,321$41.08$424.0K33,335Apr 1, 2026Apr 2, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
1,012$80.82$81.8K11,014Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
4,000$42.88$171.5K32,346Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
6,794$80.00$543.5K12,026Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
4,0000Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
12,000$40.05$480.6K28,346Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
13,526$79.17$1.07M18,820Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
12,0000Mar 3, 2026Mar 5, 2026View →
IONS
IONIS PHARMACEUTICALS INC
SALE
4,0000Nov 25, 2025Nov 28, 2025View →
IONS
IONIS PHARMACEUTICALS INC
SALE
4,0008,000Nov 25, 2025Nov 28, 2025View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
4,000$80.00$320.0K0Nov 25, 2025Nov 28, 2025View →
IONS
IONIS PHARMACEUTICALS INC
SALE
4,0004,000Nov 25, 2025Nov 28, 2025View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
4,0004,000Nov 25, 2025Nov 28, 2025View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
28,000$60.00$1.68M0Sep 3, 2025Sep 4, 2025View →
IONS
IONIS PHARMACEUTICALS INC
SALE
12,0000Sep 3, 2025Sep 4, 2025View →
IONS
IONIS PHARMACEUTICALS INC
SALE
16,0000Sep 3, 2025Sep 4, 2025View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
16,00016,000Sep 3, 2025Sep 4, 2025View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
12,00028,000Sep 3, 2025Sep 4, 2025View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
16,00016,000Sep 3, 2025Sep 4, 2025View →
IONS
IONIS PHARMACEUTICALS INC
SALE
12,0000Sep 3, 2025Sep 4, 2025View →
IONS
IONIS PHARMACEUTICALS INC
SALE
16,0000Sep 3, 2025Sep 4, 2025View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
28,000$60.00$1.68M0Sep 3, 2025Sep 4, 2025View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
12,00028,000Sep 3, 2025Sep 4, 2025View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,22013,976Jul 1, 2025Jul 2, 2025View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
11,51811,518Jul 1, 2025Jul 2, 2025View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
12,000$50.00$600.0K0Jul 16, 2024Jul 16, 2024View →
IONS
IONIS PHARMACEUTICALS INC
SALE
12,0000Jul 16, 2024Jul 16, 2024View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
12,000$24.42$293.0K12,000Jul 16, 2024Jul 16, 2024View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,0798,756Jul 1, 2024Jul 2, 2024View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
10,11110,111Jul 1, 2024Jul 2, 2024View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
682$42.94$29.3K4,000May 3, 2024May 6, 2024View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
1,269$42.59$54.0K2,731May 3, 2024May 6, 2024View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
1,318$42.57$56.1K4,682May 3, 2024May 6, 2024View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
731$42.98$31.4K2,000May 3, 2024May 6, 2024View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
1,070$42.55$45.5K930May 3, 2024May 6, 2024View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
930$42.90$39.9K0May 3, 2024May 6, 2024View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
2,000$50.00$100.0K16,346Nov 15, 2023Nov 17, 2023View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
2,000$45.13$90.3K18,346Sep 26, 2023Sep 28, 2023View →
IONS
IONIS PHARMACEUTICALS INC
SALE
3,555$42.00$149.3K20,346Jul 18, 2023Jul 19, 2023View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
5,33323,901Jul 17, 2023Jul 19, 2023View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
1,77718,568Jul 17, 2023Jul 19, 2023View →
IONS
IONIS PHARMACEUTICALS INC
SALE
5,3334,677Jul 17, 2023Jul 19, 2023View →
IONS
IONIS PHARMACEUTICALS INC
SALE
1,77710,010Jul 17, 2023Jul 19, 2023View →
IONS
IONIS PHARMACEUTICALS INC
SALE
2,000$40.00$80.0K16,791Jan 17, 2023Jan 17, 2023View →
IONS
IONIS PHARMACEUTICALS INC
SALE
5,3339,775Jul 15, 2022Jul 18, 2022View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
5,33317,459Jul 15, 2022Jul 18, 2022View →
IONS
IONIS PHARMACEUTICALS INC
SALE
2,6657,110Jul 15, 2022Jul 18, 2022View →
IONS
IONIS PHARMACEUTICALS INC
SALE
644$38.78$25.0K18,791Jul 15, 2022Jul 18, 2022View →
IONS
IONIS PHARMACEUTICALS INC
SALE
689$37.74$26.0K19,435Jul 15, 2022Jul 18, 2022View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
2,66520,124Jul 15, 2022Jul 18, 2022View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,33315,108Jul 1, 2022Jul 5, 2022View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
12,00012,000Jul 1, 2022Jul 5, 2022View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
1,77822,460Jul 15, 2021Jul 19, 2021View →
IONS
IONIS PHARMACEUTICALS INC
SALE
88912,219Jul 15, 2021Jul 19, 2021View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
5,33319,127Jul 15, 2021Jul 19, 2021View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
66620,682Jul 15, 2021Jul 19, 2021View →
IONS
IONIS PHARMACEUTICALS INC
SALE
5,33313,108Jul 15, 2021Jul 19, 2021View →
IONS
IONIS PHARMACEUTICALS INC
SALE
1,7789,775Jul 15, 2021Jul 19, 2021View →
IONS
IONIS PHARMACEUTICALS INC
SALE
66611,553Jul 15, 2021Jul 19, 2021View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
88920,016Jul 15, 2021Jul 19, 2021View →
IONS
IONIS PHARMACEUTICALS INC
SALE
4,334$35.30$153.0K18,126Jul 15, 2021Jul 19, 2021View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
12,00012,000Jul 1, 2021Jul 6, 2021View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,33318,441Jul 1, 2021Jul 6, 2021View →
IONS
IONIS PHARMACEUTICALS INC
SALE
2,889$46.86$135.4K13,794Oct 20, 2020Oct 22, 2020View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
66716,683Jul 6, 2020Jul 6, 2020View →
IONS
IONIS PHARMACEUTICALS INC
SALE
667666Jul 6, 2020Jul 6, 2020View →
IONS
IONIS PHARMACEUTICALS INC
SALE
8891,777Jul 2, 2020Jul 6, 2020View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
88916,016Jul 2, 2020Jul 6, 2020View →
IONS
IONIS PHARMACEUTICALS INC
SALE
1,7785,332Jul 1, 2020Jul 6, 2020View →
IONS
IONIS PHARMACEUTICALS INC
SALE
6660Jul 1, 2020Jul 6, 2020View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
12,00012,000Jul 1, 2020Jul 6, 2020View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
1,77815,127Jul 1, 2020Jul 6, 2020View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,3335,333Jul 1, 2020Jul 6, 2020View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
66613,349Jul 1, 2020Jul 6, 2020View →
Other insiders · IONS
Loading peer insiders…
About this filer
CIK 0001206369
ROLE
Director
PRIMARY
IONS
COMPANIES
1
ACTIVE SINCE
Jul 2020
MARKETPEEL · /INSIDER/0001206369DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback